Form 4: Organogenesis Holdings Inc. CEO Gary S. Gillheeney Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Gary S. Gillheeney, President and CEO of Organogenesis Holdings Inc., reports a transaction involving Class A Common Stock on April 1, 2024, resulting in a change in beneficial ownership.
Summary
- On April 1, 2024, Gary S. Gillheeney, the President and CEO of Organogenesis Holdings Inc., engaged in a transaction involving Class A Common Stock.
- The transaction involved the disposition of 10,113 shares at a price of $2.8.
- Following the transaction, Gillheeney directly owns 2,351,949 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction by an insider, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and alignment with company performance.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction involving Class A Common Stock |
| 04/03/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.